Neurolipidology: Interactions of nerves, neurotrophic factors, and lipids

Biomedical Reviews

Volumn 10, Issue 1, 1999, Pages 111-113

  Chaldakov, George N ^a,b   Aloe, Luigi ^a,b  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247567190     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v10.13     Document Type: Article

References (29)

1. Van Udcn E, Carlson G, St George-Hyslop P, Westaway D, Orlando R, Mallory M et al. Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): is LRP central to Alzheimer's disease pathogenesis? Mol Cell Neurosci 1999; 14:129-140.
2. Chaldakov GN, Fiorc M, Stankulov IS, Triaca V, Ghenev PI, Aloe L. Neuroimmune hypothesis of atherosclerosis. Biomed Rev 1999; 10:37-44.
3. Farcsc RV Jr, Herz J. Cholesterol metabolism and embryogenesis. Trends Genet 1998; 14:115-120.
4. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387:569-572.
5. Gimpl G, Burger K. Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistiy 1997;36:10959-10974. ''
6. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W. Nimpf J et al. Reeler/Disabled-likedisruption of neuronal migration in knockout mice lacking the VLDL receptor and App E receptor 2. Cell 1999; 97:689-701.
7. 12receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat Med 1999; 5: 656-661.
8. Cooper JA, Howell BW. Lipoprotein receptors: signaling functions in the brain? Cell 1999; 97:671-674.
9. D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 1999;24:471-479.
10. Chang JY, Liu LZ. Toxicity of cholesterol oxides on cultured neurorctinalcells. Curr Eye Res 1998; 17: 95-103.
11. Vaughan CJ, Dclanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30:1969-1973.
12. Fullerton SM, Strittmatter WJ, Mathew WD. Peripheral sensory nerve defects in apolipoprotein E knockout mice. Exp Neurol 1998; 153:156-163.
13. Verbenrcn TJ, Simonet S, Herman AG. Diet-induced atherosclerosis inhibits release of noradrenaline from sympathetic nerves in rabbitarteries. Eur J Pharmacol 1994; 270:27-34.
14. Karoon P, Burnstock G. Reduced sympathetic noradrenergic neurotransmission in the tail artery of Donryu rats fed with high cholesterol-supplemented diet. Br J Pharmacol 1998; 123:1016-1021.
15. Apfel SC. Neurotrophic factors in the therapy. Am J Med 1999; 107 (2B):34S-42S.
16. NTR and regulates neurotrophin signaling pathways. J Biol Chein 1999; 274: 257-263.
17. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzcr JL, Sargiacomo M et al. Expression of caviolin-1 and -2 in differentiating PC 12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 1998;95:10257-10262.
18. Bu G, Sun Y, Schwartz AL, Holtzman DM. Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. J Biol Client 1998;273:13359-13365.
19. Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E et al. BDNFregulates reelin expression and Cajal-Retzius cell development in the cerebral cortex. Neuron 1998;21:305-315.
20. Mukherjee SP, Mukherjee C. Similar activities of nerve growth factor and its homologue proinsulin in intracellular hydrogen peroxide production and metabolism in adipocytes. Transmembrane signalling relative to insulin-mimicking effects. Biochem Pharmacol 1982; 31: 3163-3172.
21. Ng TB, Wong CM. Epidermal and nerve growth factors manifest antilipolytic and lipogenic activities in isolated rat adipocytes. Comp Biochem Physiol (B) 1985; 81:687-689.
22. Nonogaki K, Moser AH, Shigenaga J, Feingold KR, Grunfeld C. Beta-nerve growth factor as a mediator of the acute phase response in vivo. Biochem Biophys Res Commun 1996; 219: 956-961.
23. Nonogaki K, Pan XM, Moser AH, Shigenaga J, Staprans I, Sakamoto N et al. LIF and CNTF, which share the gp130 transduction system, stimulate hepatic lipid metabolism in rats. Am J Physiol 1996;271 (3 Pt 1):E521-E528.
24. Moran CS, Campbell JH, Campbell GR. Human leukemia inhibitory factor upregulates LDL receptors on liver cells and decreases serum cholesterol in the cholesterol-fed rabbit. Arterioscler Thromb Vαsc Biol 1991;17:1267-1273.
25. Moran CS, Campbell JH, Simmons DL, Campbell GR. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis. Arterioscler Thromb 1994; 14: 1356-1363.
26. Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun 1997;238:633-637.
27. Nunes MT, Curi R. Hyperthyroid-like metabolic changes induced by chronic administration of compound BW 48/80. Brαz J Med Biol Res 1989;22:417-420.
28. Rosenbaum T, Vidaltamayo R, Sanchez-Soto MC, Zentella A, Hiriart M. Pancreatic β cells synthesize and secrete nerve growth factor. Proc Nαtl Acαd Sci USA 1998; 95:7784-7788.
29. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.